A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent-Reference-Cited by-同舟云学术

A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent

Published:2016-10-20 Issue:10 Volume:11 Page:e0164785
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sugawara Kenji,Honda Kohei,Reien Yoshie,Yokoi Norihide,Seki Chihiro,Takahashi Harumi,Minami Kohtaro,Mori Ichiro,Matsumoto Akio,Nakaya Haruaki,Seino Susumu

Funder

Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan

a research grant from MSD K.K.

a grant for Young Researchers from the Japan Association for Diabetes Education and Care

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. A review of the efficacy and safety of oral antidiabetic drugs;SA Stein;Expert Opin Drug Saf,2013

2. Electrophysiology of the pancreatic beta-cell;FM Ashcroft;Prog Biophys Mol Biol,1989

3. Molecular biology of adenosine triphosphate-sensitive potassium channels;L Aguilar-Bryan;Endocr Rev,1999

4. Triggering and amplifying pathways of regulation of insulin secretion by glucose;JC Henquin;Diabetes,2000

5. Physiological and pathophysiological roles of ATP-sensitive K+ channels;S Seino;Prog Biophys Mol Biol,2003

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of repaglinide effects on insulin secretion;European Journal of Pharmacology;2018-06

2. β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy;Diabetes, Obesity and Metabolism;2017-09

3. Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent;PLOS ONE;2017-01-12